comparemela.com

Latest Breaking News On - James shin - Page 2 : comparemela.com

Why Eli Lilly's earnings are no sure thing for traders despite obesity drug momentum

The Food and Drug Administration said supplies of Zepbound and Mounjaro are expected to be limited through the second quarter, for all but one dosage.

Mounjaro-zepbound
Eli-lilly
James-shin
Jo-walton
David-risinger
Fargo-mohit-bansal
Deutsche-bank-shin
Deutsche-bank
Drug-administration
Wall-street
Health-care-industry
Earnings

Gilead Sciences (GILD) Q1 2024 Earnings Call Transcript

GILD earnings call for the period ending March 31, 2024.

Tennessee
United-states
Japan
Maryland
Johanna-mercier
Salveen-richter-goldman-sachs
Merdad-parsey
Chris-schott-jpmorgan
Brian-abrahams
Carter-gould-barclays
Jacquie-ross
Cindy-perettie

Merck (MRK) Q1 2024 Earnings Call Transcript

MRK earnings call for the period ending March 31, 2024.

Japan
United-states
China
Chicago
Illinois
Argentina
Argentine
American
America
Luisa-hector-berenberg
Daiichi-sankyo-adcs
Seamus-fernandez

Bristol Myers Squibb (BMY) Q1 2024 Earnings Call Transcript

BMY earnings call for the period ending March 31, 2024.

Japan
Germany
United-states
Indiana
Brazil
Canada
Australia
Matt-phipps-william-blair
Chris-shibutani
Geoff-meacham
Evan-seigerman
Mohit-bansal

Merck (MRK) Q1 2024 Earnings Call Transcript

MRK earnings call for the period ending March 31, 2024.

United-states
Japan
Chicago
Illinois
China
Argentina
America
American
Argentine
Chris-schott
Seamus-fernandez
James-shin

vimarsana © 2020. All Rights Reserved.